COMPANY OVERVIEW

Asceneuron is an emerging biotech company specializing in the discovery and development of groundbreaking small molecule therapeutics for neurodegenerative diseases

---

LOCATION

Lausanne, , Switzerland

---

THERAPEUTIC AREAS

Neurodegenerative Disease

---

WEBSITE

https://www.asceneuron.com

---

CAREER WEBSITE

https://www.asceneuron.com/careers

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

May 4, 2022

Asceneuron Awarded Second Grant from The Michael J. Fox Foundation for Accelerated Research into Novel Parkinson's Disease Therapies

Apr 1, 2022

Asceneuron Publishes Pioneering Preclinical Efficacy Data on its Novel Clinical Molecule ASN90 in Both Alzheimer's and Parkinson's Disease Models

Sep 30, 2021

Asceneuron to Provide Update on O-GlcNAcase Pipeline at Upcoming Conferences

Jul 28, 2021

Asceneuron CEO Dirk Beher to Speak at Alzheimer's Association International Conference

Jul 16, 2021

Asceneuron Appoints Prominent Healthcare Leader Catherine Moukheibir to its Board of Directors USA - English USA - English

For More Press Releases

---